Exogenous cholecystokinin-8 reduces vagal efferent nerve activity in rats through CCK(A) receptors

British Journal of Pharmacology

Volumn 129, Issue 8, 2000, Pages 1649-1654

  Bucinskaite, Violeta ^a   Kurosawa, Mieko ^c   Lundeberg, Thomas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

CCK(A); CCK(B); CCK 8 receptors; Cholecystokinin 8; Vagus; Visceral efferents

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EFFERENT NERVE; MALE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; STOMACH FUNCTION; VAGOTOMY; VAGUS NERVE;

EID: 0034000709     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703270     Document Type: Article

References (25)

1. BARBER, W.D., YUAN, C.-S., BURKS, T.F., FELDMAN, J.L. & GREER, J.J. (1995). In vitro brainstem-gastric preparation with intact vagi for study of primary visceral afferent input to dorsal vagal complex in caudal medulla. J. Autonom. Nerv. Syst., 51, 181-189.
2. BRANCHEREAU, P., CHAMPAGNAT, J. & DENAVIT-SAUBIÉ, M. (1993). Cholecystokinin-gated currents in neurons of the rat solitary complex in vitro. J. Neurophysiol., 70, 2584-2595.
3. COX, J.E. & RANDICH, A. (1997). CCK-8 activates hepatic vagal C-fibre afferents. Brain Res., 776, 189-194.
4. GROSS, P.M., WALL, K.M., PANG, J.J., SHAVER, S.W. & WAINMAN, D.S. (1990). Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol., 259, R1131-R1138.
5. GRUNDY, D., BAGAEV, V. & HILLSLEY, K. (1995). Inhibition of gastric mechanoreceptor discharge by cholecystokinin in the rat. Am. J. Physiol., 268, G355-G360.
6. HAGINO, Y. & MOROJI, T. (1994). Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study. Brain Res., 644, 40-46.
7. HARRO, J., VASAR, E. & BRADWEJN, J. (1993). CCK in animal and human research of anxiety. Trends Pharmacol. Sci., 14, 244-257.
8. KUROSAWA, M., UVNÄS-MOBERG, K., MIYASAKA, K. & LUNDEBERG, T. (1997). Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rat. J. Autonom. Nerv. Syst., 62, 72-78.
9. LADURELLE, N., KELLER, G., BLOMMAERT, A., ROQUESM, B.P. & DAUGÉ, V. (1997). The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur. J. Neurosci., 9, 1804-1814.
10. LEWIS, L.D. & WILLIAMS, J.A. (1990). Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am. J. Physiol., 258, G512-G518.
11. LI, Y., HAO, Y. & OWYANG, C. (1997). High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am. J. Physiol., 273, G679-G685.
12. LIN, T.-H. & LIN, J.H. (1990). Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats. J. Pharmacol. Exp. Therap., 253, 45-50.
13. MAYNE, R.G., ARMSTRONG, W.E., CROWLEY, W.R. & BEALER, S.L. (1998). Cytoarchitcetonic analysis of Fos-immunoreactivity in brainstem neurons following visceral stimuli in conscious rats. J. Neuroendocrinol., 10, 839-847.
14. MERCER, J.G. & LAWRENCE, C.B. (1992). Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve. Neurosci. Lett., 137, 229-231.
15. MÖNNIKES, H., LAUER, G. & ARNOLD, R. (1997). Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res., 770, 277-288.
16. MORAN, T.H., BALDESSARINI, A.R., SALORIO, C.F., LOWERY, T. & SCHWARTZ, G.J. (1997). Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am. J. Physiol., 272, R1245-R1251.
17. MORAN, T.H., ROBINSON, P.H., GOLDRICH, M.S. & MCHUGH, P.R. (1986). Two brain cholecystokinin receptors: implications for behavioural actions. Brain Res., 362, 175-179.
18. OLDENDORF, W.F. (1981). Blood-brain barrier permeability to peptides: pitfalls in measurement. Peptides, 2, 109-111.
19. PLATA-SALAMÁN, C.R., FUKUDA, A., OOMURA, Y. & MINAMI, T. (1988). Effects of sulphated cholecystokinin octapeptide (CCK-8) on the dorsal motor nucleus of the vagus. Brain Res. Bull., 21, 839-842.
20. RAYBOULD, H.E. & LLOYD, K.C.K. (1994). Integration of post-prandial function in the proximal gastrointestinal tract. Ann. N.Y. Acad. Sci., 713, 143-156.
21. RAYBOULD, H.E. & TACHÉ, Y. (1988). Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am. J. Physiol., 255, G242-G246.
22. RICHARDS, W., HILLSLEY, K., EASTWOOD, C. & GRUNDY, D. (1996). Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. J. Physiol., 497, 473-481.
23. ROGERS, R.C., MCTIGUE, D.M. & HERMANN, G.E. (1995). Vagovagal reflex control of digestion: afferent modulation by neural and 'endoneurocrine' factors. Am. J. Physiol., 268, G1-G10.
24. SCWARTZ, G.J., MCHUGH, P.R. & MORAN, T.H. (1994). Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents. Am. J. Physiol., 267, R303-R308.
25. ZARBIN, M.A., WAMSLEY, J.K., INNIS, R.B. & KUHAR, M.J. (1981). Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. Life Sci., 29, 697-705.